These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 21207207

  • 1. Soluble guanylate cyclase modulators in heart failure.
    Mitrovic V, Jovanovic A, Lehinant S.
    Curr Heart Fail Rep; 2011 Mar; 8(1):38-44. PubMed ID: 21207207
    [Abstract] [Full Text] [Related]

  • 2. Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Dasgupta A, Bowman L, D'Arsigny CL, Archer SL.
    Clin Pharmacol Ther; 2015 Jan; 97(1):88-102. PubMed ID: 25670386
    [Abstract] [Full Text] [Related]

  • 3. Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure.
    Breitenstein S, Roessig L, Sandner P, Lewis KS.
    Handb Exp Pharmacol; 2017 Jan; 243():225-247. PubMed ID: 27900610
    [Abstract] [Full Text] [Related]

  • 4. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
    Reinke Y, Gross S, Eckerle LG, Hertrich I, Busch M, Busch R, Riad A, Rauch BH, Stasch JP, Dörr M, Felix SB.
    Eur J Pharmacol; 2015 Nov 15; 767():1-9. PubMed ID: 26407652
    [Abstract] [Full Text] [Related]

  • 5. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
    Boerrigter G, Burnett JC.
    Cardiovasc Drug Rev; 2007 Nov 15; 25(1):30-45. PubMed ID: 17445086
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Soluble guanylate cyclase stimulators in pulmonary hypertension.
    Stasch JP, Evgenov OV.
    Handb Exp Pharmacol; 2013 Nov 15; 218():279-313. PubMed ID: 24092345
    [Abstract] [Full Text] [Related]

  • 8. Role of guanylate cyclase modulators in decompensated heart failure.
    Mitrovic V, Hernandez AF, Meyer M, Gheorghiade M.
    Heart Fail Rev; 2009 Dec 15; 14(4):309-19. PubMed ID: 19568931
    [Abstract] [Full Text] [Related]

  • 9. The chemistry and biology of soluble guanylate cyclase stimulators and activators.
    Follmann M, Griebenow N, Hahn MG, Hartung I, Mais FJ, Mittendorf J, Schäfer M, Schirok H, Stasch JP, Stoll F, Straub A.
    Angew Chem Int Ed Engl; 2013 Sep 02; 52(36):9442-62. PubMed ID: 23963798
    [Abstract] [Full Text] [Related]

  • 10. Riociguat for the treatment of pulmonary hypertension.
    Hambly N, Granton J.
    Expert Rev Respir Med; 2015 Sep 02; 9(6):679-95. PubMed ID: 26599488
    [Abstract] [Full Text] [Related]

  • 11. Hemodynamic Effects of a Soluble Guanylate Cyclase Stimulator, Riociguat, and an Activator, Cinaciguat, During NO-Modulation in Healthy Pigs.
    Næsheim T, How OJ, Myrmel T.
    J Cardiovasc Pharmacol Ther; 2021 Jan 02; 26(1):75-87. PubMed ID: 32662299
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Soluble Guanylate Cyclase Stimulators and Activators.
    Sandner P, Zimmer DP, Milne GT, Follmann M, Hobbs A, Stasch JP.
    Handb Exp Pharmacol; 2021 Jan 02; 264():355-394. PubMed ID: 30689085
    [Abstract] [Full Text] [Related]

  • 14. The safety and effectiveness of riociguat to treat chronic thromboembolic pulmonary hypertension.
    DeSouza SA, Preston IR.
    Expert Rev Cardiovasc Ther; 2015 May 02; 13(5):467-76. PubMed ID: 25797801
    [Abstract] [Full Text] [Related]

  • 15. Renal effects of soluble guanylate cyclase stimulators and activators: a review of the preclinical evidence.
    Stasch JP, Schlossmann J, Hocher B.
    Curr Opin Pharmacol; 2015 Apr 02; 21():95-104. PubMed ID: 25645316
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cinaciguat, a soluble guanylate cyclase activator for the potential treatment of acute heart failure.
    Tamargo J, Duarte J, Caballero R, Delpón E.
    Curr Opin Investig Drugs; 2010 Sep 02; 11(9):1039-47. PubMed ID: 20730699
    [Abstract] [Full Text] [Related]

  • 18. Riociguat: first global approval.
    Conole D, Scott LJ.
    Drugs; 2013 Nov 02; 73(17):1967-75. PubMed ID: 24218053
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.